116
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Abstract submission is now open for RExPO25, the 4th International Conference on Systems Medicine, AI & Drug Repurposing.  Submit your proposal for a talk or poster and join us in Barcelona, Spain, September 24-26, 2025. 

      Deadline for abstracts is June 30, 2025

      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Unlocking drug repurposing clinical trials: resources for investigators

      Preprint
      In review
      research-article
      Bookmark

            Abstract

            Content

            Author and article information

            Journal
            DrugRxiv
            REPO4EU
            7 October 2024
            Affiliations
            [1 ] 3D-PharmXchange;
            Author notes
            Author information
            https://orcid.org/0009-0004-1063-3482
            Article
            10.58647/DRUGARXIV.PR000016.v1
            119a0679-b6e3-4a78-be79-4511ec54e5a7

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            : 7 October 2024
            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Life sciences
            Drug repurposing,Innovative clinical trial designs,Investigator initiated trials,Mechanism-based network pharmacology,Phase II clinical trials

            Comments

            Comment on this article